This grant is for advancing evidence-based treatment research, primarily supporting Stage I treatment development. It focuses on developing, manualizing, and pilot testing novel or adapted treatments, or refining existing interventions to prepare for broader efficacy trials. Research conducted will yield crucial feasibility, tolerability, and acceptability data, along with pilot information for subsequent larger-scale studies. The program specifically targets behavioral, combined, sequential, or integrated behavioral and pharmacological interventions. Key areas include drug abuse treatment (including comorbidities), preventing HIV acquisition/transmission among individuals in drug abuse treatment, promoting adherence to drug abuse treatment and addiction medications, and treating chronic pain. This R34 mechanism facilitates foundational research in these critical health domains.
Opportunity ID: 49866
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-10-013 |
Funding Opportunity Title: | Behavioral and Integrative Treatment Development Program (R34) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Oct 14, 2009 |
Last Updated Date: | Nov 02, 2010 |
Original Closing Date for Applications: | Jan 07, 2013 |
Current Closing Date for Applications: | Jan 07, 2013 |
Archive Date: | Feb 07, 2013 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Independent school districts City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Small businesses Public housing authorities/Indian housing authorities County governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Purpose. The purpose of this R34 Funding Opportunity Announcement (FOA) is to advance evidence-based treatment research through 1) the development, manualization, standardization, early-stage efficacy and/or pilot testing of novel or adapted treatments and/or interventions (i.e. Stage 1 treatment research, see below), 2) the refinement, modification, adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale efficacy or effectiveness trials, or 3) novel treatment research that requires preliminary testing or development. It is expected that research conducted via this R34 mechanism will primarily consist of Stage I treatment development research that will provide feasibility, tolerability, and acceptability information and/or pilot data for larger scale Stage II or Stage III behavioral and integrative treatment studies. This FOA seeks to support research, as described above, within the domains of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. Mechanism of Support. This FOA will use the R34 mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-012, which encourages applications under the Research Project Grant (R01) mechanism, and PA-10-011 which encourages applications under the NIH Small Research Grant (R03) mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-10-013.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Removed CFDA number 93.272 | Nov 02, 2010 | |
Nov 02, 2010 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-10-013 |
Funding Opportunity Title: | Behavioral and Integrative Treatment Development Program (R34) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Oct 14, 2009 |
Last Updated Date: | Nov 02, 2010 |
Original Closing Date for Applications: | Jan 07, 2013 |
Current Closing Date for Applications: | Jan 07, 2013 |
Archive Date: | Feb 07, 2013 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Independent school districts City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Small businesses Public housing authorities/Indian housing authorities County governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Purpose. The purpose of this R34 Funding Opportunity Announcement (FOA) is to advance evidence-based treatment research through 1) the development, manualization, standardization, early-stage efficacy and/or pilot testing of novel or adapted treatments and/or interventions (i.e. Stage 1 treatment research, see below), 2) the refinement, modification, adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale efficacy or effectiveness trials, or 3) novel treatment research that requires preliminary testing or development. It is expected that research conducted via this R34 mechanism will primarily consist of Stage I treatment development research that will provide feasibility, tolerability, and acceptability information and/or pilot data for larger scale Stage II or Stage III behavioral and integrative treatment studies. This FOA seeks to support research, as described above, within the domains of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. Mechanism of Support. This FOA will use the R34 mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-012, which encourages applications under the Research Project Grant (R01) mechanism, and PA-10-011 which encourages applications under the NIH Small Research Grant (R03) mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-10-013.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-10-013 |
Funding Opportunity Title: | Behavioral and Integrative Treatment Development Program (R34) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.272 — Alcohol National Research Service Awards for Research Training |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 02, 2010 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Jan 07, 2013 |
Archive Date: | Feb 07, 2013 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments For profit organizations other than small businesses Independent school districts City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Private institutions of higher education Public housing authorities/Indian housing authorities Small businesses Special district governments Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Purpose. The purpose of this R34 Funding Opportunity Announcement (FOA) is to advance evidence-based treatment research through 1) the development, manualization, standardization, early-stage efficacy and/or pilot testing of novel or adapted treatments and/or interventions (i.e. Stage 1 treatment research, see below), 2) the refinement, modification, adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale efficacy or effectiveness trials, or 3) novel treatment research that requires preliminary testing or development. It is expected that research conducted via this R34 mechanism will primarily consist of Stage I treatment development research that will provide feasibility, tolerability, and acceptability information and/or pilot data for larger scale Stage II or Stage III behavioral and integrative treatment studies. This FOA seeks to support research, as described above, within the domains of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. Mechanism of Support. This FOA will use the R34 mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-012, which encourages applications under the Research Project Grant (R01) mechanism, and PA-10-011 which encourages applications under the NIH Small Research Grant (R03) mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-10-013.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.279 | ADOBE-FORMS-B1 | Supersedes ADOBE-FORMS-B | PKG00022330 | Nov 03, 2010 | Jan 07, 2013 | View |
ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00015624 | Jan 16, 2010 | Nov 03, 2010 | View |
Package 1
Mandatory forms
49866 RR_SF424_1_2-1.2.pdf
49866 RR_OtherProjectInfo_1_3-1.3.pdf
49866 RR_KeyPersonExpanded_1_2-1.2.pdf
49866 PerformanceSite_1_4-1.4.pdf
49866 PHS398_ResearchPlan_1_3-1.3.pdf
49866 PHS398_CoverPageSupplement_1_4-1.4.pdf
49866 PHS398_Checklist_1_3-1.3.pdf
Optional forms
49866 RR_Budget-1.1.pdf
49866 RR_SubawardBudget-1.2.pdf
49866 PHS_CoverLetter_1_2-1.2.pdf
49866 PHS398_ModularBudget-1.1.pdf
Package 2
Mandatory forms
49866 RR_SF424_1_2-1.2.pdf
49866 PerformanceSite_1_3-1.3.pdf
49866 RR_OtherProjectInfo_1_2-1.2.pdf
49866 RR_KeyPersonExpanded_1_2-1.2.pdf
49866 PHS398_CoverPageSupplement_1_4-1.4.pdf
49866 PHS398_ResearchPlan_1_3-1.3.pdf
49866 PHS398_Checklist_1_3-1.3.pdf
Optional forms
49866 PHS_CoverLetter_1_2-1.2.pdf
49866 PHS398_ModularBudget-1.1.pdf
49866 RR_Budget-1.1.pdf
49866 RR_SubawardBudget-1.2.pdf